Page last updated: 2024-09-03

y 27632 and Progeria

y 27632 has been researched along with Progeria in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Choi, HJC; Choi, K; Jung, CW; Kang, HT; Kim, GR; Lee, YS; Park, JT; Park, SC1
Cho, KA; Kang, HT; Lee, YS; Park, CH; Park, JT; Park, SC1

Other Studies

2 other study(ies) available for y 27632 and Progeria

ArticleYear
Chemical screening identifies ROCK as a target for recovering mitochondrial function in Hutchinson-Gilford progeria syndrome.
    Aging cell, 2017, Volume: 16, Issue:3

    Topics: Amides; Amino Acid Sequence; Cells, Cultured; Cytochromes c; DNA Breaks, Double-Stranded; Fibroblasts; Gene Expression Regulation; HEK293 Cells; High-Throughput Screening Assays; Humans; Mitochondria; Phosphorylation; Progeria; Protein Binding; Protein Kinase Inhibitors; Pyridines; rac1 GTP-Binding Protein; Reactive Oxygen Species; rho-Associated Kinases; Sequence Alignment; Sequence Homology, Amino Acid; Signal Transduction; Two-Hybrid System Techniques

2017
A crucial role of ROCK for alleviation of senescence-associated phenotype.
    Experimental gerontology, 2018, Volume: 106

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Amides; Animals; Cell Proliferation; Cellular Senescence; Child; Chromatin; Fibroblasts; Humans; Male; Mice; Mice, Inbred C57BL; Phenotype; Progeria; Pyridines; rho-Associated Kinases; Wound Healing

2018